Rx groups blast DIR reversal
WASHINGTON — Pharmacy organizations have decried the government’s refusal to reform direct and indirect remuneration (DIR) fees in its new drug pricing rule. “We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies,” said a statement from the National Association